secwatch.observer — SEC 8-K summary
======================================

Issuer:     Entrada Therapeutics, Inc. (TRDA)
CIK:        0001689375
Form:       8-K
Filed at:   2022-03-22T23:59:59+00:00
Accession:  0001104659-22-036320
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Entrada Therapeutics signs 10-year lease for ~81,442 sq ft HQ in Boston
-----------------------------------------------------------------------

- Lease for fifth and sixth floors of One Design Center Place, Boston; 10-year term with 5-year renewal option.
- Initial base rent ~$525,417/month for first 12 months (based on 65,000 sq ft), then 3% annual increases for full 81,442 sq ft.
- Landlord provides up to ~$19.5M tenant improvement allowance ($240/sq ft) and additional ~$1.63M contribution repayable over 10 years at 8% interest.
- Rent commencement is earlier of occupancy or 10 months after delivery; expected delivery around April 1, 2022.
- Security deposit of ~$3.95M in letter of credit; Landlord's Work includes pre- and post-delivery improvements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1689375/000110465922036320/0001104659-22-036320-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1689375/000110465922036320/tm228415d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-036320

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer